DK0505640T4 - Forbedret terapeutisk metode - Google Patents

Forbedret terapeutisk metode

Info

Publication number
DK0505640T4
DK0505640T4 DK91308457T DK91308457T DK0505640T4 DK 0505640 T4 DK0505640 T4 DK 0505640T4 DK 91308457 T DK91308457 T DK 91308457T DK 91308457 T DK91308457 T DK 91308457T DK 0505640 T4 DK0505640 T4 DK 0505640T4
Authority
DK
Denmark
Prior art keywords
therapeutic method
agent
improved therapeutic
antifolate
inhibitor
Prior art date
Application number
DK91308457T
Other languages
Danish (da)
English (en)
Other versions
DK0505640T3 (da
Inventor
Gerald Burr Grindey
Shih Chuan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24717023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0505640(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK0505640T3 publication Critical patent/DK0505640T3/da
Application granted granted Critical
Publication of DK0505640T4 publication Critical patent/DK0505640T4/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK91308457T 1991-03-29 1991-09-17 Forbedret terapeutisk metode DK0505640T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67703191A 1991-03-29 1991-03-29

Publications (2)

Publication Number Publication Date
DK0505640T3 DK0505640T3 (da) 1995-12-27
DK0505640T4 true DK0505640T4 (da) 2002-12-16

Family

ID=24717023

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91308457T DK0505640T4 (da) 1991-03-29 1991-09-17 Forbedret terapeutisk metode

Country Status (12)

Country Link
EP (1) EP0505640B2 (fr)
JP (1) JP3468534B2 (fr)
AT (1) ATE126700T1 (fr)
AU (1) AU640524B2 (fr)
CA (1) CA2051520C (fr)
CY (1) CY1888A (fr)
DE (1) DE69112376T3 (fr)
DK (1) DK0505640T4 (fr)
ES (1) ES2077808T5 (fr)
GR (1) GR3017774T3 (fr)
HK (1) HK161495A (fr)
ZA (1) ZA917406B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
WO2002002093A2 (fr) * 2000-06-30 2002-01-10 Eli Lilly And Company Nouvelles polytherapies aux antifolates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
US4999424A (en) * 1988-11-10 1991-03-12 The Pennsylvania State University GAR transformylase inhibitor
CH676981A5 (fr) 1988-11-11 1991-03-28 Eprova Ag
US5008391A (en) * 1989-07-07 1991-04-16 Eli Lilly And Company Enantioselective synthesis of antifolates

Also Published As

Publication number Publication date
GR3017774T3 (en) 1996-01-31
EP0505640B2 (fr) 2002-02-27
DK0505640T3 (da) 1995-12-27
ES2077808T3 (es) 1995-12-01
EP0505640A1 (fr) 1992-09-30
DE69112376T2 (de) 1996-03-14
AU640524B2 (en) 1993-08-26
DE69112376D1 (de) 1995-09-28
JPH0597705A (ja) 1993-04-20
HK161495A (en) 1995-10-20
CY1888A (en) 1996-04-05
ATE126700T1 (de) 1995-09-15
AU8457091A (en) 1992-10-01
JP3468534B2 (ja) 2003-11-17
EP0505640B1 (fr) 1995-08-23
CA2051520C (fr) 2003-02-18
DE69112376T3 (de) 2002-08-14
CA2051520A1 (fr) 1992-09-30
ZA917406B (en) 1993-03-17
ES2077808T5 (es) 2002-10-16

Similar Documents

Publication Publication Date Title
NO942283L (no) Pyrofeoforbider og deres anvendelse i fotodynamisk terapi
NO971085D0 (no) Vannopplöselig polymer og peptid modifisert med denne
NO992373D0 (no) Forlenget anestesi i ledd og kroppshulrom
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
NO974151D0 (no) 6-substituerte pyrazolo (3,4-d) pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav
DE69217736T2 (de) Inhibierte Acryloxy- und Methacryloxysilanen
NO934282D0 (no) Kalsium, spormetall, vitamin D og medisinterapikombinasjoner
DE69230654D1 (de) Commiphora-Mukul-Extrakte und deren therapeutische Verwendung
NO974150D0 (no) 6-arylpyrazolo(3,4-d)pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav
DK194091D0 (da) Hydrofil og biokompatibel coatede overflader
FI914598A (fi) Foerfarande i en med optisk princip fungerande ankomstkoppling
DK0505640T3 (da) Forbedret terapeutisk metode
ATA147691A (de) Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung
IS4387A (is) Nýtt skömmtunarform hýdroxókóbalamíns og notkun þess við sýaníðeitrunum
IS4140A (is) Notkun á ferróseni og/eða ferrósenafleiðum
DE69309582T2 (de) Endlos Formularsatz und dadurch erstelltes Poststück
ZA92357B (en) Amide derivatives and their therapeutic use.
NO175398C (no) Ventillegeme og kuleventil
ES2113765T3 (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaespiro(4.5)decano-2-propanamina.
DE9315895U1 (de) Spezieller Notdurft- und Mehrzweckstuhl
BR9100982A (pt) Injetor de gas e valvula de retensao
DE29516554U1 (de) Zirkel mit zwei Hauptschenkeln und einem Nebenschenkel
BR7301816U (pt) Bola mágica
KR940021845U (ko) 사우나겸용 다용도 온돌메트리스(mattress)
DK296490D0 (da) Praeserveringsmiddel og anvendelse heraf